Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Döcke W[au]:

Mechanisms involved in the side effects of glucocorticoids. Schäcke H et al. Pharmacol Ther. (2002)

T cell pathology in skin inflammation. Sabat R et al. Semin Immunopathol. (2019)

The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction. Witte-Händel E et al. J Invest Dermatol. (2019)

Search results

Items: 1 to 50 of 112

1.

T cell pathology in skin inflammation.

Sabat R, Wolk K, Loyal L, Döcke WD, Ghoreschi K.

Semin Immunopathol. 2019 May;41(3):359-377. doi: 10.1007/s00281-019-00742-7. Epub 2019 Apr 26. Review.

2.

The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.

Witte-Händel E, Wolk K, Tsaousi A, Irmer ML, Mößner R, Shomroni O, Lingner T, Witte K, Kunkel D, Salinas G, Jodl S, Schmidt N, Sterry W, Volk HD, Giamarellos-Bourboulis EJ, Pokrywka A, Döcke WD, Schneider-Burrus S, Sabat R.

J Invest Dermatol. 2019 Jun;139(6):1294-1305. doi: 10.1016/j.jid.2018.11.018. Epub 2018 Dec 5.

PMID:
30528824
3.

Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

von Haehling S, Wolk K, Höflich C, Kunz S, Grünberg BH, Döcke WD, Reineke U, Asadullah K, Sterry W, Volk HD, Sabat R.

Genes Immun. 2015 Jul-Aug;16(5):366. doi: 10.1038/gene.2015.9. No abstract available.

PMID:
26201975
4.

Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

von Haehling S, Wolk K, Höflich C, Kunz S, Grünberg BH, Döcke WD, Reineke U, Asadullah K, Sterry W, Volk HD, Sabat R.

Genes Immun. 2015 Jan-Feb;16(1):8-14. doi: 10.1038/gene.2014.69. Epub 2014 Dec 4. Erratum in: Genes Immun. 2015 Jul-Aug;16(5):366. von Lanzenauer, S H [corrected to von Haehling, S].

PMID:
25472783
5.

Induction of overt menstruation in intact mice.

Rudolph M, Döcke WD, Müller A, Menning A, Röse L, Zollner TM, Gashaw I.

PLoS One. 2012;7(3):e32922. doi: 10.1371/journal.pone.0032922. Epub 2012 Mar 7.

6.

Extended DNFB-induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses.

Röse L, Schneider C, Stock C, Zollner TM, Döcke WD.

Exp Dermatol. 2012 Jan;21(1):25-31. doi: 10.1111/j.1600-0625.2011.01395.x.

PMID:
22151387
7.

Willingness to Donate Human Samples for Establishing a Dermatology Research Biobank: Results of a Survey.

Gross D, Schmitz AA, Vonk R, Igney FH, Döcke WD, Schoepe S, Sterry W, Asadullah K.

Biopreserv Biobank. 2011 Sep;9(3):265-271.

8.

Persistent CMV infection correlates with disease activity and dominates the phenotype of peripheral CD8+ T cells in psoriasis.

Weitz M, Kiessling C, Friedrich M, Prösch S, Höflich C, Kern F, Volk HD, Sterry W, Asadullah K, Döcke WD.

Exp Dermatol. 2011 Jul;20(7):561-7. doi: 10.1111/j.1600-0625.2011.01250.x. Epub 2011 Mar 16.

PMID:
21410770
9.

Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases.

von Bonin A, Rausch A, Mengel A, Hitchcock M, Krüger M, von Ahsen O, Merz C, Röse L, Stock C, Martin SF, Leder G, Döcke WD, Asadullah K, Zügel U.

Exp Dermatol. 2011 Jan;20(1):41-7. doi: 10.1111/j.1600-0625.2010.01198.x.

PMID:
21158938
10.

The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis.

Wolk K, Witte E, Warszawska K, Schulze-Tanzil G, Witte K, Philipp S, Kunz S, Döcke WD, Asadullah K, Volk HD, Sterry W, Sabat R.

Eur J Immunol. 2009 Dec;39(12):3570-81. doi: 10.1002/eji.200939687.

11.

The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation.

Schottelius AJ, Zügel U, Döcke WD, Zollner TM, Röse L, Mengel A, Buchmann B, Becker A, Grütz G, Naundorf S, Friedrich A, Gaestel M, Asadullah K.

J Invest Dermatol. 2010 Feb;130(2):481-91. doi: 10.1038/jid.2009.218. Epub 2009 Aug 6.

12.

Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Schäcke H, Zollner TM, Döcke WD, Rehwinkel H, Jaroch S, Skuballa W, Neuhaus R, May E, Zügel U, Asadullah K.

Br J Pharmacol. 2009 Oct;158(4):1088-103. doi: 10.1111/j.1476-5381.2009.00238.x. Epub 2009 May 6.

13.

IL-10 protects monocytes and macrophages from complement-mediated lysis.

Koch N, Jung M, Sabat R, Krätzschmar J, Döcke WD, Asadullah K, Volk HD, Grütz G.

J Leukoc Biol. 2009 Jul;86(1):155-66. doi: 10.1189/jlb.0708443. Epub 2009 Apr 22.

PMID:
19386697
14.

Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis.

Döcke WD, Asadullah K, Belbe G, Ebeling M, Höflich C, Friedrich M, Sterry W, Volk HD.

J Leukoc Biol. 2009 Mar;85(3):582-93. doi: 10.1189/jlb.0408249. Epub 2008 Nov 26.

PMID:
19038787
15.

Chronic mouse model of TMA-induced contact hypersensitivity.

Schneider C, Döcke WD, Zollner TM, Röse L.

J Invest Dermatol. 2009 Apr;129(4):899-907. doi: 10.1038/jid.2008.307. Epub 2008 Oct 2.

16.

Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type.

Schoenbein C, Docke WD, Wolk K, Belbe G, Hoflich C, Jung M, Grutz G, Sterry W, Volk HD, Asadullah K, Sabat R.

Clin Exp Immunol. 2008 Feb;151(2):306-16. Epub 2007 Dec 6.

17.

Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes.

Lingnau M, Höflich C, Volk HD, Sabat R, Döcke WD.

Hum Immunol. 2007 Sep;68(9):730-8. Epub 2007 Jul 17.

PMID:
17869646
18.

Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate.

Mirshahpanah P, Döcke WD, Merbold U, Asadullah K, Röse L, Schäcke H, Zollner TM.

Exp Dermatol. 2007 Sep;16(9):753-61.

PMID:
17697148
19.

Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells.

Listopad J, Asadullah K, Sievers C, Ritter T, Meisel C, Sabat R, Döcke WD.

Exp Dermatol. 2007 Aug;16(8):661-70.

PMID:
17620093
20.

Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1.

Lehmann JC, Listopad JJ, Rentzsch CU, Igney FH, von Bonin A, Hennekes HH, Asadullah K, Docke WD.

J Invest Dermatol. 2007 Apr;127(4):835-45. Epub 2007 Jan 18.

21.

Reduced monocyte CD86 expression in postinflammatory immunodeficiency.

Wolk K, Höflich C, Zuckermann-Becker H, Döcke WD, Volk HD, Sabat R.

Crit Care Med. 2007 Feb;35(2):458-67.

PMID:
17204999
22.

IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis.

Wolk K, Witte E, Wallace E, Döcke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R.

Eur J Immunol. 2006 May;36(5):1309-23.

23.

Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study.

Döcke WD, Höflich C, Davis KA, Röttgers K, Meisel C, Kiefer P, Weber SU, Hedwig-Geissing M, Kreuzfelder E, Tschentscher P, Nebe T, Engel A, Monneret G, Spittler A, Schmolke K, Reinke P, Volk HD, Kunz D.

Clin Chem. 2005 Dec;51(12):2341-7. Epub 2005 Oct 7.

24.

Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy.

Jung M, Sabat R, Krätzschmar J, Seidel H, Wolk K, Schönbein C, Schütt S, Friedrich M, Döcke WD, Asadullah K, Volk HD, Grütz G.

Eur J Immunol. 2004 Feb;34(2):481-93.

25.

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.

Schäcke H, Schottelius A, Döcke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, Asadullah K.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):227-32. Epub 2003 Dec 23.

26.

Stress induced IL-10 does not seem to be essential for early monocyte deactivation following cardiac surgery.

Volk T, Döpfmer UR, Schmutzler M, Rimpau S, Schnitzler H, Konertz W, Hoeflich C, Döcke WD, Spies CD, Volk HD, Kox WJ.

Cytokine. 2003 Dec 21;24(6):237-43.

PMID:
14609565
27.

The pathophysiological role of cytokines in psoriasis.

Asadullah K, Döcke WD, Volk HD, Sterry W.

Drugs Today (Barc). 1999 Dec;35(12):913-24.

PMID:
12973418
28.

Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.

Höflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Döcke WD, Grütz G, Meisel C, Halle E, Göbel UB, Volk HD, Suttorp N.

Blood. 2004 Jan 15;103(2):673-5. Epub 2003 Aug 28.

PMID:
12947000
29.

Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis.

Döcke WD, Kiessling C, Worm M, Friedrich M, Pruss A, Weitz M, Prösch S, Kern F, Volk HD, Sterry W, Asadullah K.

Br J Dermatol. 2003 May;148(5):954-63.

PMID:
12786826
30.

Mechanisms involved in the side effects of glucocorticoids.

Schäcke H, Döcke WD, Asadullah K.

Pharmacol Ther. 2002 Oct;96(1):23-43. Review.

PMID:
12441176
31.

Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis.

Friedrich M, Döcke WD, Klein A, Philipp S, Volk HD, Sterry W, Asadullah K.

J Invest Dermatol. 2002 Apr;118(4):672-7.

32.

Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis.

Friedrich M, Sterry W, Klein A, Rückert R, Döcke WD, Asadullah K.

Acta Derm Venereol. 2001 Nov-Dec;81(6):429-30. No abstract available.

33.

Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients.

Woiciechowsky C, Schöning B, Cobanov J, Lanksch WR, Volk HD, Döcke WD.

J Trauma. 2002 Feb;52(2):339-45.

PMID:
11834998
34.

Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass.

Volk T, Schmutzler M, Engelhardt L, Döcke WD, Volk HD, Konertz W, Kox WJ.

Crit Care Med. 2001 Nov;29(11):2137-42.

PMID:
11700410
35.

Leukocyte/endothelium activation and interactions during femoral percutaneous transluminal angioplasty.

Lüdemann J, Schulte KL, Hader O, Brehme S, Volk HD, Döcke WD.

Vasc Surg. 2001 Jul-Aug;35(4):293-301.

PMID:
11586455
36.

Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies.

Sabat R, Höflich C, Döcke WD, Oppert M, Kern F, Windrich B, Rosenberger C, Kaden J, Volk HD, Reinke P.

Intensive Care Med. 2001 Jun;27(6):987-91.

PMID:
11497157
37.

Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings.

Asadullah K, Friedrich M, Hanneken S, Rohrbach C, Audring H, Vergopoulos A, Ebeling M, Döcke WD, Volk HD, Sterry W.

J Invest Dermatol. 2001 May;116(5):721-7.

38.

Release of WBC-derived IL-1 receptor antagonist into supernatants of RBCs: influence of storage time and filtration.

Büttnerova I, Bäumler H, Kern F, Radtke H, Volk HD, Kiesewetter H, Döcke WD.

Transfusion. 2001 Jan;41(1):67-73.

PMID:
11161248
39.

Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype.

Friedrich M, Krammig S, Henze M, Döcke WD, Sterry W, Asadullah K.

Arch Dermatol Res. 2000 Oct;292(10):519-21. No abstract available.

PMID:
11142774
40.

Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells.

Riese U, Brenner S, Döcke WD, Prösch S, Reinke P, Oppert M, Volk HD, Platzer C.

Mol Cell Biochem. 2000 Sep;212(1-2):45-50.

PMID:
11108135
41.

The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.

Asadullah K, Döcke WD, Sabat RV, Volk HD, Sterry W.

Expert Opin Investig Drugs. 2000 Jan;9(1):95-102. Review.

PMID:
11060663
42.

IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.

Asadullah K, Haeussler-Quade A, Gellrich S, Hanneken S, Hansen-Hagge TE, Döcke WD, Volk HD, Sterry W.

Exp Dermatol. 2000 Aug;9(4):248-51.

PMID:
10949545
44.

Impaired antigen presentation by human monocytes during endotoxin tolerance.

Wolk K, Döcke WD, von Baehr V, Volk HD, Sabat R.

Blood. 2000 Jul 1;96(1):218-23.

PMID:
10891454
45.

Immunological monitoring of the inflammatory process: Which variables? When to assess?

Volk HD, Reinke P, Döcke WD.

Eur J Surg Suppl. 1999;(584):70-2.

PMID:
10890238
46.

A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation.

Prösch S, Wendt CE, Reinke P, Priemer C, Oppert M, Krüger DH, Volk HD, Döcke WD.

Virology. 2000 Jul 5;272(2):357-65.

47.

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.

Felix SB, Staudt A, Dörffel WV, Stangl V, Merkel K, Pohl M, Döcke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G.

J Am Coll Cardiol. 2000 May;35(6):1590-8.

48.

Comparison of monocyte functions after LPS- or IL-10-induced reorientation: importance in clinical immunoparalysis.

Wolk K, Döcke W, von Baehr V, Volk H, Sabat R.

Pathobiology. 1999;67(5-6):253-6.

PMID:
10725796
49.
50.

Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes.

Prösch S, Döcke WD, Reinke P, Volk HD, Krüger DH.

Intervirology. 1999;42(5-6):308-13. Review.

PMID:
10702711

Supplemental Content

Support Center